URZENA Trademark

Trademark Overview


On Tuesday, December 14, 2021, a trademark application was filed for URZENA with the United States Patent and Trademark Office. The USPTO has given the URZENA trademark a serial number of 97171526. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, August 7, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The URZENA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the integumentary system, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, bacterial, viral, fungal, and parasitic infections, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation
urzena

General Information


Serial Number97171526
Word MarkURZENA
Filing DateTuesday, December 14, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the integumentary system, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, bacterial, viral, fungal, and parasitic infections, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Thursday, September 29, 2022NON-FINAL ACTION WRITTEN
Thursday, September 29, 2022NON-FINAL ACTION E-MAILED
Thursday, September 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 17, 2021NEW APPLICATION ENTERED
Friday, December 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Tuesday, October 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 18, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 7, 2022EXAMINER'S AMENDMENT ENTERED
Monday, November 7, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, November 7, 2022EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 4, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 4, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 22, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 4, 2023SOU EXTENSION 1 FILED
Thursday, February 1, 2024SOU EXTENSION 2 GRANTED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2024SOU EXTENSION 2 FILED
Wednesday, August 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 7, 2024SOU EXTENSION 3 FILED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED